Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment

Figure 4

Forest plot based on disease-free survival and tumor stage. (a) DFS in OX/FU-based group versus FU-based group in patients with ypStage II; (b) DFS in OX/FU-based group versus FU-based group in patients with ypStage III; (c) DFS in OX/FU-based group versus FU-based group in patients with clinical stage II; (d) DFS in OX/FU-based group versus FU-based group in patients with clinical stage III.

(a)

(b)

(c)

(d)